Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QUANTIFY: QVA149 vs Tiotropium + Formoterol in COPD
NCT01574651Phase 3Completed
- Sponsor
- Novartis
- Start
- May 2012
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of indacaterol + glycopyrronium in chronic obstructive pulmonary disease (COPD), sponsored by Novartis. Started May 2012; status: completed.
02
Drugs
indacaterol + glycopyrronium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01574651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01574651.